In PreLynx #sanitizer a #nanopolymer disinfectant vapor containing a potent #virucidal agent inactivates all of the lipophilic viruses including herpes, influenza, and #coronavirus within twenty minutes.
#Silica-coated #iron_oxide nanoparticles have a strong affinity for #RNA that can be used to extract #coronavirus RNA from a solution containing a sample from the patient.
The #nanomaterials with enzyme-like characteristics developed by Chinese researchers can absorb and deactivate the #coronavirus (SARS-CoV-2) with 96.5 - 99.9 percent efficiency.
Recent Alnylam advances in lung delivery technology suggest the possible utility of #RNAi therapeutic for the treatment of new #coronavirus disease (COVID-19).
#Ad5_nCoV is a genetically engineered #vaccine candidate with the replication-defective #adenovirus type 5 as a vector to express the spike protein of the novel #coronavirus (SARS-CoV-2).
#mRNA technology has been widely used in many #nanotechnology_patents focusing on the #coronavirus (SARS / MERS) treatment approaches.
Around 5.2 percent (478 patents) of all #coronavirus related patents so far registered are in the field of #nanotechnology.
New #COVID_19 vaccine candidate has been developed using proprietary #recombinant_protein nanoparticle technology platform to generate antigens derived from the #coronavirus spike (S) protein.
Integrating a proprietary #nanorod technology into a #lateral_flow_test platform resulted in developing of a rapid screening test for the current #coronavirus, nCoV19.
Carbon #quantum_dots functionalized with boronic acid ligands can interfere with the function of #coronavirus S protein and significantly inhibit its entry into the host cells.
